Qvanteq was among the finalists of the Pionierpreis 2012. 15 companies have been nominated.
A portrait of Qvanteq AG was published in the the Swiss journal “20minuten” under the the title “Weniger Herzinfarkte dank neuer Stent-Technologie”. Full article (g).
Qvanteq AG closed a Series A financing round to achieve proof of concept for its novel stent technology. The round was assisted by investiere.ch through a successful co-funding.
Arik Zucker is one of the winners of the venture leader USA program.